HPS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.060950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.687000E-01
Normal-vs-Stage2
1.516150E-01
Normal-vs-Stage3
4.048300E-02
Normal-vs-Stage4
4.846600E-01
Stage1-vs-Stage2
1.355950E-01
Stage1-vs-Stage3
1.656020E-02
Stage1-vs-Stage4
4.753000E-01
Stage2-vs-Stage3
8.215800E-02
Stage2-vs-Stage4
6.987600E-01
Stage3-vs-Stage4
1.008170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.130610E-01
Normal-vs-AfricanAmerican
2.284600E-01
Normal-vs-Asian
2.866400E-01
Caucasian-vs-AfricanAmerican
4.964300E-02
Caucasian-vs-Asian
6.722800E-01
AfricanAmerican-vs-Asian
2.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.602350E-01
Normal-vs-Female
6.367600E-02
Male-vs-Female
6.322000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.748430E-01
Normal-vs-Age(41-60Yrs)
3.677800E-01
Normal-vs-Age(61-80Yrs)
2.753500E-02
Normal-vs-Age(81-100Yrs)
3.423400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.958800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.382200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.645000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.375800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.117400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.602210E-01
Normal-vs-Daily Drinker
4.585900E-02
Normal-vs-Weekly Drinker
3.809600E-02
Normal-vs-Occasional Drinker
2.431400E-01
Normal-vs-Social Drinker
3.399400E-01
Non Drinker-vs-Daily Drinker
2.726800E-01
Non Drinker-vs-Weekly Drinker
3.183800E-01
Non Drinker-vs-Occasional Drinker
7.440400E-01
Non Drinker-vs-Social Drinker
3.347000E-01
Daily Drinker-vs-Weekly Drinker
9.809400E-01
Daily Drinker-vs-Occasional Drinker
1.946620E-01
Daily Drinker-vs-Social Drinker
5.143800E-02
Weekly Drinker-vs-Occasional Drinker
2.247400E-01
Weekly Drinker-vs-Social Drinker
5.950200E-02
Occasional Drinker-vs-Social Drinker
5.586800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.602960E-01
Normal-vs-Grade 2
3.126000E-02
Normal-vs-Grade 3
7.533900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.797800E-02
Grade 1-vs-Grade 3
3.877900E-03
Grade 1-vs-Grade 4
1.602960E-01
Grade 2-vs-Grade 3
5.278100E-02
Grade 2-vs-Grade 4
3.126000E-02
Grade 3-vs-Grade 4
7.533900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.054100E-02
Normal-vs-NonDiabetic
9.406000E-02
Diabetic-vs-NonDiabetic
5.939200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.073800E-01
Normal-vs-NoPancreatitis
6.609800E-02
Pancreatitis-vs-NoPancreatitis
5.791600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.178300E-02
Normal-vs-N1
1.453030E-01
N0-vs-N1
4.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.154000E-01
Normal-vs-TP53-NonMutant
6.294200E-02
TP53-Mutant-vs-TP53-NonMutant
2.222300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
